Sharon Barbari's Insider Trades & SAST Disclosures
Sharon Barbari's most recent trade in VYNE Therapeutics Inc was a trade of 20,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sharon Barbari.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VYNE Therapeutics Inc | Sharon Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| VYNE Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| VYNE Therapeutics Inc | Surrey-Barbari Sharon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 1,065 | 1,065 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 935 | 974 (0%) | 0% | 0 | Common Stock | |
| VYNE Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 20,500 | 20,500 | - | - | Stock Options | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 807 | 807 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 670 | 1,952 (0%) | 0% | 0 | Common Stock | |
| VYNE Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 20,500 | 20,500 | - | - | Stock Options | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 29,905 | 29,905 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 24,510 | 51,296 (0%) | 0% | 0 | Common Stock | |
| VYNE Therapeutics Inc | Sharon Surrey-Barbari | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2020 | 75,000 | 13,971 | - | - | Stock Options | |
| VYNE Therapeutics Inc | Sharon Surrey-Barbari | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.48 per share. | 20 Aug 2020 | 75,000 | 75,000 (0%) | 0% | 1.5 | 111,000 | Common Stock |
| VYNE Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 22,500 | 22,500 | - | - | Stock Options | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 45,212 | 45,212 | - | - | Employee Stock Option (Right to Buy) | |
| Agile Therapeutics Inc | Sharon Surrey-Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2020 | 26,786 | 26,786 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges